Gene · 58484
Papers3,844
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 3,844
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The NLRP3 Inflammasome: Mechanisms of Activation, Regulation, and Therapeutic Opportunities. | MedComm (2020) | 2026 | 41799937 | PubTator, text mining | PubMed |
| Inflammation-modulating agents in chronic limb-threatening ischemia: a narrative review of therapeutic potential and future directions. | Ann Med Surg (Lond) | 2026 | 41789236 | PubTator, text mining | PubMed |
| Age-related increase of NLRC4 inflammasome and TGF-β1 signaling exacerbates airway inflammation and remodeling in asthma. | Geroscience | 2026 | 41774086 | PubTator, text mining | PubMed |
| PRRSV-2 impedes lysosomes from eliminating secondary infected bacteria. | PLoS Pathog | 2026 | 41758870 | PubTator, text mining | PubMed |
| Advances in delivery technologies-powered cancer vaccines. | Bioact Mater | 2026 | 41756688 | PubTator, text mining | PubMed |
| Antiviral Inflammasomes and How to Find Them. | Viruses | 2026 | 41754516 | PubTator, text mining | PubMed |
| Role of Nod-like Receptors in Helicobacter pylori Infection: Insights into Innate Immune Signaling Pathways. | Microorganisms | 2026 | 41753558 | PubTator, text mining | PubMed |
| The Role of Non-LTR Retrotransposons in Sterile Inflammation: Mechanisms and Therapeutic Potential. | Biomedicines | 2026 | 41751171 | PubTator, text mining | PubMed |
| Multiomics approaches in Kawasaki disease: insights into pathogenesis and emerging directions for diagnosis and treatment. | Clin Exp Pediatr | 2026 | 41736230 | PubTator, text mining | PubMed |
| Role of autophagy in antiviral innate immunity. | Cell Mol Biol Lett | 2026 | 41735833 | PubTator, text mining | PubMed |
| The effects of high-intensity interval training on NLRP3 inflammasome and monocyte chemokine receptors in individuals with obesity. | PLoS One | 2026 | 41729927 | PubTator, text mining | PubMed |
| Macrophage makeover extreme viral edition: mechanisms of immune subversion and therapeutic perspectives. | J Gen Virol | 2026 | 41729693 | PubTator, text mining | PubMed |
| Defining alteration in bone marrow mesenchymal stem cells (MSC) from acute myeloid leukemia and exploring cultured MSC-conditioned media as a novel anti-leukemia therapy agent. | Cancer Immunol Immunother | 2026 | 41729306 | PubTator, text mining | PubMed |
| Targeting pyroptosis in periodontitis: mechanisms and therapeutic strategies. | Front Immunol | 2026 | 41727505 | PubTator, text mining | PubMed |
| Role of insulin-regulated aminopeptidase as potential biomarker in insulin resistant polycystic ovary syndrome patients. | Arch Endocrinol Metab | 2026 | 41719418 | PubTator, text mining | PubMed |
| Integrated single-cell and transcriptomic profiling identifies machine-learning-based pyroptosis biomarkers in IBD. | Front Immunol | 2026 | 41716401 | PubTator, text mining | PubMed |
| Monogenic forms of inflammatory bowel disease: Genetic mechanisms, models, and clinical implications. | Mol Med | 2026 | 41714924 | PubTator, text mining | PubMed |
| Novel strategies for identification and prevention of idiosyncratic liver injury caused by TCM compatibility: Exemplification by Epimedii Folium and Psoraleae Fructus. | Phytomedicine | 2026 | 41655541 | PubTator, text mining | PubMed |
| Modulation of inflammasome components in patients with heart failure using oral nutritional supplements: investigating the molecular mechanisms beyond the clinical benefit. | Eur J Nutr | 2026 | 41632188 | PubTator, text mining | PubMed |
| Evaluation of ASC as a therapeutic target for Alzheimer's disease. | Alzheimers Dement | 2026 | 41582303 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/58484/papers?page=3